BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32723981)

  • 21. Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors.
    Lai JP; Mertens RB; Mirocha J; Koo J; Venturina M; Chung F; Mendez AB; Kahn M; Dhall D
    Endocr Pathol; 2015 Mar; 26(1):54-62. PubMed ID: 25433656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin.
    Koo J; Mertens RB; Mirocha JM; Wang HL; Dhall D
    Mod Pathol; 2012 Jun; 25(6):893-901. PubMed ID: 22388755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens.
    Chi Z; Xu J; Karamchandani DM; Peng L
    Diagn Pathol; 2023 Apr; 18(1):54. PubMed ID: 37098593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma.
    McKnight R; Cohen C; Siddiqui MT
    Cancer Cytopathol; 2010 Oct; 118(5):298-302. PubMed ID: 20572292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas.
    Lawlor RT; Daprà V; Girolami I; Pea A; Pilati C; Nottegar A; Piccoli P; Parolini C; Sperandio N; Capelli P; Scarpa A; Luchini C
    Virchows Arch; 2019 Jan; 474(1):105-109. PubMed ID: 30132130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
    Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
    Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin: A comparative study with their pulmonary counterparts.
    Bi Y; Deng Y; Li S; Zhou X; Chen Y; Ma D; Mao X; Guan Y; Chen J; Meng Y
    J Surg Oncol; 2016 Nov; 114(6):697-702. PubMed ID: 27761900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and significance of INSM1 and SOX11 in pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm].
    Cao Z; Cen HB; Zhao JH; Mei J; Qin LZ; Liao W; Ao QL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):575-581. PubMed ID: 37534634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.
    Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N
    World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABCD1 as a Novel Diagnostic Marker for Solid Pseudopapillary Neoplasm of the Pancreas.
    Liu YA; Liu Y; Tu J; Shi Y; Pang J; Huang Q; Wang X; Lin Z; Zhao Y; Wang W; Peng J; Wu W
    Am J Surg Pathol; 2024 May; 48(5):511-520. PubMed ID: 38567813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ki67 index evaluation of pancreatic neuroendocrine tumors using 3D immunohistochemistry in small tissue specimens.
    Ikeda E; Shinozaki S; Sakaguchi M; Sano N; Kabasawa S; Kanno A; Ando K; Yokoyama K; Tamada K; Onodera H; Yamamoto H; Fukushima N
    Pancreatology; 2023 Aug; 23(5):537-542. PubMed ID: 37301696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can We Identify Nephrogenic Adenoma in Urine Cytology Specimens? A Study Evaluating Previously Described Cytomorphologic Features in Correlation With PAX8 Immunohistochemical Staining Results.
    McCroskey Z; Pambuccian SE; Wojcik EM; Barkan GA
    Am J Clin Pathol; 2016 Mar; 145(3):373-8. PubMed ID: 27124920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large, clear cytoplasmic vacuolation: an under-recognized cytologic clue to distinguish solid pseudopapillary neoplasms of the pancreas from pancreatic endocrine neoplasms on fine-needle aspiration.
    Jhala N; Siegal GP; Jhala D
    Cancer; 2008 Aug; 114(4):249-54. PubMed ID: 18484644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic significance of PAX8 in thyroid squamous cell carcinoma.
    Suzuki A; Hirokawa M; Takada N; Higuchi M; Yamao N; Kuma S; Daa T; Miyauchi A
    Endocr J; 2015; 62(11):991-5. PubMed ID: 26354716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Diagnostic Utility of PAX8 for Neuroendocrine Tumors: An Immunohistochemical Reappraisal.
    Liau JY; Tsai JH; Jeng YM; Kuo KT; Huang HY; Liang CW; Yang CY
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):57-63. PubMed ID: 25710581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two unusual variants of pancreatic neuroendocrine tumor and their potential pitfalls on fine-needle aspiration cytology.
    Richmond AM; Mehrotra S
    Diagn Cytopathol; 2017 Apr; 45(4):371-378. PubMed ID: 28217985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates.
    Bellevicine C; Iaccarino A; Malapelle U; Sasso FC; Biondi B; Troncone G
    Eur J Endocrinol; 2013 Sep; 169(3):307-11. PubMed ID: 23811186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.
    Umetsu SE; Kakar S; Basturk O; Kim GE; Chatterjee D; Wen KW; Hale G; Shafizadeh N; Cho SJ; Whitman J; Gill RM; Jones KD; Navale P; Bergsland E; Klimstra D; Joseph NM
    Mod Pathol; 2023 Mar; 36(3):100065. PubMed ID: 36788102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ß-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association With Endometrioid Type II Stem Cell Outgrowths in the Fallopian Tube.
    Xu J; McGregor SM; Park KJ; Weisman PS
    Int J Gynecol Pathol; 2024 Mar; 43(2):145-148. PubMed ID: 37922952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.